🇺🇸 Intrathecal dexmedetomidine in United States

Intrathecal dexmedetomidine (Intrathecal dexmedetomidine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intrathecal dexmedetomidine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intrathecal dexmedetomidine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intrathecal dexmedetomidine in United States?

Tanta University is the originator. The local marketing authorisation holder may differ — check the official source linked above.